Status:
UNKNOWN
Perfusion Index Changes in Cardiovascular Autonom Neuropathia Type-2 Dm Whit Spinal Anesthesia
Lead Sponsor:
Erzincan University
Conditions:
Anesthesia; Adverse Effect
Eligibility:
All Genders
18+ years
Brief Summary
Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardia...
Detailed Description
Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardia...
Eligibility Criteria
Inclusion
- the patient will be operated with spinal anesthesia
- over 18 years
- no additional disease and only DM
Exclusion
- patients with additional disease
- patients under 18 years of age
- patients contraindicated in spinal anesthesia
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT03869775
Start Date
December 1 2017
End Date
December 1 2020
Last Update
March 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erzincanu
Erzincan, Merkez, Turkey (Türkiye), 24050